Pricing Log in Create free account

Boston Scientific Corporation (BSX) vs DexCom, Inc. (DXCM)

Boston Scientific Corporation and DexCom, Inc. are both Medical Devices companies. Boston Scientific Corporation is the larger, with a market value of $64.7B against $31.5B — 2.1× the size. Boston Scientific Corporation trades at the lower P/E: 18.7× against 32.6×. DexCom, Inc. grew revenue faster over the last twelve months: 13.0% against 8.87%. DexCom, Inc. has the higher net margin (19.4% vs 16.6%) and the higher return on invested capital (39.0% vs 6.60%). Across the 22 metrics below, Boston Scientific Corporation leads on 11 and DexCom, Inc. on 11.

Valuation

Metric BSX DXCM Medical Devices median
P/E 18.72 32.61 25.58
P/S 3.05 6.20 2.54
P/B 2.48 12.48 2.48
Price to free cash flow 19.29 28.81 28.81
EV/EBITDA 14.00 21.24 11.51
EV/Sales 3.59 6.24 2.72
Earnings yield 5.34% 3.07% (12.82%)
Free cash flow yield 5.18% 3.47% (8.18%)

Profitability

Metric BSX DXCM Medical Devices median
Gross margin 69.14% 63.42% 57.76%
Operating margin 18.65% 23.98% (15.07%)
Net margin 16.62% 19.41% (14.45%)
Free cash flow margin 15.81% 21.52% (3.88%)
Return on equity 14.15% 37.67% (10.35%)
Return on assets 7.94% 14.43% (17.26%)
Return on invested capital 6.60% 39.00% (5.27%)

Growth

Metric BSX DXCM Medical Devices median
Revenue growth (TTM) 8.87% 13.03% 10.41%
EPS growth (last fiscal year) 55.20% 47.18% 28.17%
Revenue growth, 5-year CAGR 15.16% 19.33% 15.74%
Net income growth, 5-year CAGR 0.00% 8.75% 0.00%

Health

Metric BSX DXCM Medical Devices median
Debt to equity 0.46 0.49 0.04
Current ratio 1.36 1.74 2.74
Net debt to EBITDA 1.88 (0.65) 0.54

Dividend

Metric BSX DXCM Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric BSX DXCM Medical Devices median
Market cap 64.70b 31.50b 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack